Antibodies

Once-daily valacyclovir to reduce the risk of transmission of genital herpes.

Once-daily valacyclovir to reduce the risk of transmission of genital herpes.

BACKGROUNDNucleoside analogues in opposition to herpes simplex virus (HSV) have been proven to suppress shedding of HSV kind 2 (HSV-2) on genital mucosal surfaces and should forestall sexual
Glycoprotein-D-adjuvant vaccine to prevent genital herpes.

Glycoprotein-D-adjuvant vaccine to prevent genital herpes.

BACKGROUND An efficient prophylactic vaccine would assist management the unfold of genital herpes.METHODSWe performed two double-blind, randomized trials of a herpes simplex virus kind 2 (HSV-2)